172 related articles for article (PubMed ID: 8625771)
1. Histamine H2-receptor antagonists stimulate proliferation but not migration of human gastric mucosal cells in vitro.
Ciacci C; Zarrilli R; Ricci V; De Luca A; Mazzacca G; Del Vecchio Blanco C; Romano M
Dig Dis Sci; 1996 May; 41(5):972-8. PubMed ID: 8625771
[TBL] [Abstract][Full Text] [Related]
2. Structural requirements for roxatidine in the stimulant effect of rat gastric mucin synthesis and the participation of nitric oxide in this mechanism.
Ichikawa T; Ishihara K; Saigenji K; Hotta K
Br J Pharmacol; 1997 Nov; 122(6):1230-6. PubMed ID: 9401791
[TBL] [Abstract][Full Text] [Related]
3. Comparison of antiproliferative effects of 1-histamine-2 receptor antagonists, cimetidine, ranitidine, and famotidine, in gastric cancer cells.
Hahm KB; Park IS; Kim HC; Lee KJ; Kim JH; Cho SW; Lee SI
Int J Immunopharmacol; 1996; 18(6-7):393-9. PubMed ID: 9024941
[TBL] [Abstract][Full Text] [Related]
4. Comparative pharmacology of histamine H2-receptor antagonists.
Sewing KF; Beil W; Hannemann H
Drugs; 1988; 35 Suppl 3():25-9. PubMed ID: 2905246
[TBL] [Abstract][Full Text] [Related]
5. Cytoprotective action of roxatidine acetate HCl.
Shiratsuchi K; Fuse H; Hagiwara M; Mikami T; Miyasaka K; Sakuma H
Arch Int Pharmacodyn Ther; 1988; 294():295-304. PubMed ID: 2906796
[TBL] [Abstract][Full Text] [Related]
6. A histamine H2 receptor antagonist, roxatidine, stimulates mucus secretion and synthesis by cultured rabbit gastric mucosal cells.
Takahashi S; Okabe S
J Physiol Pharmacol; 1995 Dec; 46(4):503-11. PubMed ID: 8770793
[TBL] [Abstract][Full Text] [Related]
7. Ranitidine and cimetidine differ in their in vitro and in vivo effects on human colonic cancer growth.
Lawson JA; Adams WJ; Morris DL
Br J Cancer; 1996 Apr; 73(7):872-6. PubMed ID: 8611398
[TBL] [Abstract][Full Text] [Related]
8. [Effects of various histamine H2-receptor antagonists on gastrointestinal motility and gastric emptying].
Ohira Y; Hanyu N; Aoki T; Hashimoto Y; Iikura M; Fukuda S
J Smooth Muscle Res; 1993 Aug; 29(4):131-42. PubMed ID: 7907895
[TBL] [Abstract][Full Text] [Related]
9. Effects of a new histamine H2-receptor antagonist, Z-300, on gastric secretion and gastro-duodenal lesions in rats: comparison with roxatidine.
Okabe S; Takagi K; Igata H; Kato S; Shimosako K; Yamaji Y; Seiki M
Jpn J Pharmacol; 1992 Jul; 59(3):275-89. PubMed ID: 1359178
[TBL] [Abstract][Full Text] [Related]
10. The effects of roxatidine acetate (HOE-760) on 24-hour intragastric acidity in healthy volunteers: comparison with ranitidine and placebo.
Merki HS; Witzel L; Kaufmann D; Kempf M; Müssig V; Neumann J; Scheurle E; Röhmel J; Walt RP
Aliment Pharmacol Ther; 1988 Feb; 2(1):73-81. PubMed ID: 2908751
[TBL] [Abstract][Full Text] [Related]
11. JB-9322, a new selective histamine H2-receptor antagonist with potent gastric mucosal protective properties.
Palacios B; Montero MJ; Sevilla MA; Román LS
Br J Pharmacol; 1995 May; 115(1):57-66. PubMed ID: 7647984
[TBL] [Abstract][Full Text] [Related]
12. Chemical and biologic characteristics of roxatidine acetate.
Bickel M; Herling AW; Schoelkens B; Scholtholt J
Scand J Gastroenterol Suppl; 1988; 146():78-88. PubMed ID: 2906471
[TBL] [Abstract][Full Text] [Related]
13. The effects of roxatidine acetate on 24-hour intragastric acidity. Investigations in healthy volunteers and comparison with ranitidine and placebo.
Merki HS; Witzel L; Kaufmann D; Kempf M; Neumann J; Scheurle E; Röhmel J; Walt RP
Drugs; 1988; 35 Suppl 3():69-75. PubMed ID: 2905252
[TBL] [Abstract][Full Text] [Related]
14. Different effects of two types of H2-receptor antagonists, famotidine and roxatidine, on the mucus barrier of rat gastric mucosa.
Shikama N; Ichikawa T; Iwai T; Yamamoto H; Kida M; Koizumi W; Ishihara K
Biomed Res; 2012 Feb; 33(1):45-51. PubMed ID: 22361886
[TBL] [Abstract][Full Text] [Related]
15. Stimulatory effect of transforming growth factor-alpha on gastric epithelial cell migration through proliferation.
Nakajima N; Kuwayama H
J Clin Gastroenterol; 1995; 21 Suppl 1():S45-9. PubMed ID: 8774990
[TBL] [Abstract][Full Text] [Related]
16. Activity of the new histamine H2-receptor antagonist zolantidine at cardiac and gastric H2-receptors.
Coruzzi G; Adami M; Pozzoli C; Poli E; Bertaccini G
Pharmacology; 1994 Feb; 48(2):69-76. PubMed ID: 7907797
[TBL] [Abstract][Full Text] [Related]
17. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
Sekiguchi H; Hamada K; Taga F; Nishino K
Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
[TBL] [Abstract][Full Text] [Related]
18. Histamine H2-receptor antagonism of T-593, an anti-ulcer agent: studies on aminopyrine accumulation in isolated canine gastric mucosal cells.
Inoie M; Marubuchi S; Arai H
Jpn J Pharmacol; 1998 Nov; 78(3):313-22. PubMed ID: 9869265
[TBL] [Abstract][Full Text] [Related]
19. Assessment of intragastric acidity in man: modern aspects, reproducibility of intragastric pH-monitoring, and pharmacodynamic results obtained with H2-receptor antagonists.
Merki HS; Witzel L; Kaufmann D; Kempf M; Muessig V; Neumann J; Scheurle E; Roehmel J; Walt RP
Scand J Gastroenterol Suppl; 1988; 146():142-52. PubMed ID: 2906458
[TBL] [Abstract][Full Text] [Related]
20. Adaptation of gastric mucosa to stress. Effect of ranitidine.
Ernst H; Konturek PC; Brzozowski T; Lochs H; Hahn EG; Konturek SJ
J Physiol Pharmacol; 1998 Sep; 49(3):405-19. PubMed ID: 9789793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
